IMMUNOGLOBULIN-G ISOTYPE CHANGES IN HUMAN SPORADIC AMYOTROPHIC-LATERAL-SCLEROSIS (ALS)

被引:7
|
作者
WESTARP, ME [1 ]
BARTMANN, P [1 ]
KORNHUBER, HH [1 ]
机构
[1] UNIV ULM,DEPT PEDIAT,D-89070 ULM,GERMANY
关键词
AMYOTROPHIC LATERAL SCLEROSIS; HUMAN SPUMA RETROVIRUS; IMMUNOGLOBULINS; IMMUNOGLOBULIN-G ISOTYPES; MOTOR NEURON DISEASE;
D O I
10.1016/0304-3940(94)90164-3
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Out of 50 patients with sporadic amyotrophic lateral sclerosis (sALS), excluding 8 patients with recent immunosuppressive medication or low total IgG, we examined all available 92 sera of 1 1 women and 31 men nephelometrically for serum immunoglobulin concentrations including IgG isotypes IgG(1-4). Mean serum levels of IgA and IgM remained within references in all cases. Isotypes IgG(1) and IgG(3) were the most frequently altered immunoglobulins. Without specific treatment, 34 out of 42 patients ( = 80%) and 58 out of 92 sera ( = 63%) demonstrated low IgG(3) concentrations ( < 0.41 g/l), while 14 patients ( = 33%) and 20 sera ( = 22%) demonstrated low IgG, serum levels ( < 4.22 g/l). In patients with normal total IgG, isotypes IgG, and IgG, often changed in a complementary way, and IgG(1)/IgG(2) serum concentrations correlated significantly (r(s) = -0.518, P < 0.001). In four longitudinally monitored patients, the IgG(3) isotype ranged from 1.3% to 8.2% of serum IgG and demonstrated a remarkable individual variability over time, corresponding to the relatively short half-life of IgG(3). Since elevated circulating immune complexes may fluctuate rapidly, altered serum immunoglobulin isotypes could become more convenient parameters in a still enigmatic disease. To assess their role and relevance, their association with clinical course, cerebrospinal fluid and circulating immune complexes has to be examined.
引用
收藏
页码:124 / 126
页数:3
相关论文
共 50 条
  • [41] TRH AND AMYOTROPHIC-LATERAL-SCLEROSIS
    MITSUMOTO, H
    HANSON, MR
    SALANGA, VD
    SALGADO, E
    NEUROLOGY, 1987, 37 (01) : 175 - 176
  • [42] SCHIZOPHRENIA AND AMYOTROPHIC-LATERAL-SCLEROSIS
    HOWLAND, RH
    COMPREHENSIVE PSYCHIATRY, 1990, 31 (04) : 327 - 336
  • [43] AMYOTROPHIC-LATERAL-SCLEROSIS WITH DEMENTIA
    CAVALLERI, F
    DERENZI, E
    ACTA NEUROLOGICA SCANDINAVICA, 1994, 89 (05): : 391 - 394
  • [44] AMYOTROPHIC-LATERAL-SCLEROSIS - PREFACE
    BROOKS, BR
    NEUROLOGIC CLINICS, 1987, 5 (01) : R11 - R13
  • [45] AMYOTROPHIC-LATERAL-SCLEROSIS IN PREGNANCY
    LUPO, VR
    RUSTERHOLZ, JH
    REICHERT, JA
    HANSON, AS
    OBSTETRICS AND GYNECOLOGY, 1993, 82 (04): : 682 - 685
  • [46] THE DIAGNOSIS OF AMYOTROPHIC-LATERAL-SCLEROSIS
    POUGET, J
    AZULAY, JP
    BILLETURC, F
    SANGLA, I
    SERRATRICE, GT
    PATHOGENESIS AND THERAPY OF AMYOTROPHIC LATERAL SCLEROSIS, 1995, 68 : 143 - 152
  • [47] CEFTRIAXONE IN AMYOTROPHIC-LATERAL-SCLEROSIS
    NORRIS, FH
    ARCHIVES OF NEUROLOGY, 1994, 51 (05) : 447 - 447
  • [48] RILUZOLE IN AMYOTROPHIC-LATERAL-SCLEROSIS
    MACRAE, KD
    NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (04): : 272 - 273
  • [49] REINNERVATION IN AMYOTROPHIC-LATERAL-SCLEROSIS
    WAKATA, N
    BRENNER, J
    ADELMAN, LS
    KELLY, JJ
    MUNSAT, TL
    NEUROLOGY, 1986, 36 (04) : 138 - 138
  • [50] A CONTROLLED TRIAL OF RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR (RHCNTF) IN AMYOTROPHIC-LATERAL-SCLEROSIS (ALS)
    MILLER, RG
    ARMON, C
    BAROHN, R
    BRYAN, W
    GOODPASTURE, J
    PARRY, G
    PETAJAN, J
    ROSS, M
    STROMATT, S
    NEUROLOGY, 1995, 45 (04) : A281 - A281